AEON Biopharma, Inc. (AEON) vs CASI Pharmaceuticals Inc. (CASIF)
AEON Biopharma, Inc. and CASI Pharmaceuticals Inc. are both Biotechnology companies. AEON Biopharma, Inc. and CASI Pharmaceuticals Inc. are of similar size ($12.7M and $12.4M). AEON Biopharma, Inc. has the higher net margin (0.00% vs −232.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, AEON Biopharma, Inc. leads on 8 and CASI Pharmaceuticals Inc. on 3.
Valuation
Profitability
| Metric | AEON | CASIF | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 48.65% | 65.16% |
| Operating margin | 0.00% | (206.87%) | 0.00% |
| Net margin | 0.00% | (232.03%) | 0.00% |
| Free cash flow margin | 0.00% | (432.54%) | 0.00% |
| Return on equity | 350.00% | 0.00% | (57.72%) |
| Return on assets | (621.70%) | 0.00% | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack